Events
ASCO 2025: Sacituzumab govitecan helps some patients with PD-L1-positive triple-negative breast cancer live longer without cancer progression
- ASCO 2025: Artificial intelligence assistance can help improve accuracy in identifying HER2-low and HER2-ultralow breast cancers, avoid misclassification
- Global warming may raise women’s cancer risk
- ESMO Breast 2025: Immunotherapy research shows promising results for patients with advanced HER2-positive breast cancer
New gene-editing therapy shows early success in advanced GI cancers
- Cancer Council Victoria’s statewide Bowel Screening Campaign results
- SALSA: A new artificial intelligence tool for the automated and precise analysis of liver tumours
- AACR 2025: A topical BRAF-inhibiting gel may mitigate acneiform rash in patients receiving EGFR-targeted therapy for colorectal cancer
Teletrials right on target
When it comes to cancer care, all things are not equal. That’s especially true for people living in rural and…










